• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Beta Bionics, Inc. - Common Stock (NQ:BBNX)

19.34 +0.94 (+5.11%)
Delayed Quote Updated: 4:00 PM EDT, Oct 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 685,199
Open 18.40
Bid (Size) 18.00 (300)
Ask (Size) 20.24 (500)
Prev. Close 18.40
Today's Range 18.23 - 19.38
52wk Range 8.800 - 32.71
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNX
Today 15:04 EDT
From SkyMedia, LLC
Via GlobeNewswire
News headline image
Kaplan Fox Urges Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Seek a Leadership Role Before November 3, 2026
Today 11:10 EDT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit

Performance

52-Week Range 40.9% below 52-week high
19.34
8.8052W Low 32.7152W High
1 Week
16.321W Low 18.501W High

Beta Bionics, Inc. - Common Stock (BBNX) traded between $8.80 and $32.71 over the past 52 weeks and last traded at $19.34, 40.9% below its 52-week high. Over the past week it ranged between $16.32 and $18.50.

Past 12 Months
+11.7%
-12.3%
+18.6%
+58.5%
-33.9%
-7.8%
1W +$2.03
1M -$2.70
3M +$3.03
6M +$7.14
YTD -$9.91
1Y -$1.64

BBNX was -7.8% over the past year, +58.5% over six months, -33.9% year to date, +11.7% in the last week.

12 Months vs Market
BBNX
-7.8%
DIA
+12.5%
SPY
+13.8%
QQQ
+15.2%
IWM
+12.0%

Over the past 12 months BBNX returned -7.8% versus DIA (Dow) +12.5%, SPY (S&P 500) +13.8%, QQQ (Nasdaq 100) +15.2% and IWM (Russell 2000) +12.0%.

Volume & Liquidity 0.51× 3-mo avg
Today 685,199 3-mo avg 1.4M
1W
1.2M
1M
1.1M
3M
1.4M
6M
1.1M
YTD
1.2M
1Y
1.1M

BBNX most recently traded 685,199 shares against a 3-month average daily volume of 1.4M.

More News

Read More
News headline image
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
Today 11:03 EDT
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Beta Bionics, Inc. (NASDAQ: BBNX); GoDaddy Inc. (NYSE: GDDY); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is Investigating Claims on Your
Today 8:29 EDT
From Grabar Law Office
Via GlobeNewswire
News headline image
BETA BIONICS, INC. (BBNX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Beta Bionics, Inc. Investors of Upcoming Deadline
Today 8:22 EDT
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Kaplan Fox Reminds Investors of a Deadline for a Securities Fraud Class Action Lawsuit Against Beta Bionics, Inc. (NASDAQ: BBNX) on November 3, 2026
October 21, 2026
From Kaplan Fox & Kilsheimer, LLP
Via GlobeNewswire
News headline image
Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
October 20, 2026
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
BBNX ALERT: Bragar Eagel & Squire, P.C. Urges Beta Bionics, Inc. Investors to Contact the Firm Regarding Their Rights
October 20, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBNX
October 20, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors Seeking Recovery to Contact the Firm Before November 3, 2026
October 20, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
BBNX DEADLINE: SueWallSt Reminds Beta Bionics, Inc. Investors of Upcoming Securities Class Action Deadline
October 20, 2026
From SueWallSt
Via GlobeNewswire
News headline image
Kaplan Fox Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors to the Lead Plaintiff Deadline on November 3, 2026
October 19, 2026
From Kaplan Fox & Kilsheimer, LLP
Via GlobeNewswire
News headline image
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
October 19, 2026
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
BBNX Shareholder Alert: Beta Bionics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
October 19, 2026
From Levi & Korsinsky, LLP
Via GlobeNewswire
News headline image
Kaplan Fox Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors to a Securities Fraud Lawsuit - Lead Plaintiff Deadline is November 3, 2026
October 16, 2026
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
BBNX DEADLINE: Levi & Korsinsky Reminds Beta Bionics, Inc. Investors of Upcoming Securities Class Action Deadline
October 16, 2026
From Levi & Korsinsky, LLP
Via ACCESS Newswire
News headline image
Kaplan Fox Urges Beta Bionics, Inc. (NASDAQ: BBNX) Investors Seeking Recovery to Contact the Firm Before November 3, 2026
October 16, 2026
From Kaplan Fox & Kilsheimer, LLP
Via GlobeNewswire
News headline image
Kaplan Fox Advises Investors of Beta Bionics, Inc. (NASDAQ: BBNX) of an Upcoming Securities Class Action Deadline on November 3, 2026
October 15, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNX
October 15, 2026
From SkyMedia, LLC
Via GlobeNewswire
News headline image
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
October 15, 2026
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
Kaplan Fox Reminds Investors of the November 3, 2026 Deadline in the Securities Class Action Against Beta Bionics, Inc. (NASDAQ: BBNX)
October 15, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
Kaplan Fox Announces the Lead Plaintiff Deadline of November 3, 2026 in the Securities Class Action Against Beta Bionics, Inc. (NASDAQ: BBNX)
October 14, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
Kaplan Fox Advises Beta Bionics, Inc. (NASDAQ: BBNX) Investors of a Securities Class Action Deadline on November 3, 2026
October 14, 2026
From Kaplan Fox & Kilsheimer, LLP
Via GlobeNewswire
News headline image
Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
October 13, 2026
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
Kaplan Fox Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors to an Approaching Lead Plaintiff Deadline on November 3, 2026
October 13, 2026
Via NewMediaWire
Topics Lawsuit

Frequently Asked Questions

Is Beta Bionics, Inc. - Common Stock publicly traded?
Yes, Beta Bionics, Inc. - Common Stock is publicly traded.
What exchange does Beta Bionics, Inc. - Common Stock trade on?
Beta Bionics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Beta Bionics, Inc. - Common Stock?
The ticker symbol for Beta Bionics, Inc. - Common Stock is BBNX on the Nasdaq Stock Market
What is the current price of Beta Bionics, Inc. - Common Stock?
The current price of Beta Bionics, Inc. - Common Stock is 19.34
When was Beta Bionics, Inc. - Common Stock last traded?
The last trade of Beta Bionics, Inc. - Common Stock was at 10/22/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap